Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis

Keith C HayesDepartment of Physical Medicine and Rehabilitation, The University of Western Ontario, London, ON, CanadaAbstract: Dalfampridine extended release (ER) 10 mg is an oral tablet form of the potassium (K+) channel-blocking compounded dalfampridine, also known as fampridine, and chemically&a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Hayes KC
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://doaj.org/article/ca611cb145b34bab91b18fb7e442dcf5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!